This blog explores how the fixed-dose combination of Pantoprazole 40 mg + Domperidone 10 mg delivers a dual-action advantage in GERD and acid-related disorders. By combining Pantoprazole’s powerful acid suppression with Domperidone’s prokinetic action, it ensures faster relief, improved gastric motility, and long-lasting patient comfort. The article highlights its clinical superiority over monotherapy, regulatory acceptance, and formulation excellence by Walter Healthcare, ma

Pharmaceutical packaging: not just a container, but a vital protector. It's the silent guardian ensuring your medicine remains safe,...

From tariff shocks to “Buy American” pressures, Trump’s policies tested Indian pharma’s resilience. Yet, in the world’s largest drug...

Explore high-impact opportunities as branded and blockbuster drugs lose patent protection in India between 2025-2027. Gain insights into...